US$ 25.89
blue cross blue shield semaglutide Does Cover (Wegovy) Blue Cross Blue Shield of
Description
Clinical evidence includes studies documenting reduced alcohol consumption, fewer drinks per day, and decreased alcohol craving with semaglutide treatment

doi: 10.1038/s41586-024-07419-8

This multi pathway approach is designed to support appetite control, improved insulin response, and higher energy use

Gradual escalation gives the GI system time to adapt

Some patients with favorable genetic profiles maintain active weight loss for 1824 months, while others benefit most from a 612 month intensive phase followed by maintenance dosing
